IDXXIDEXX Laboratories, Inc.

$47B

Q2 2018 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$581M+14.1% YoY

Gross Profit

$332M57.2% margin

Operating Income

$146M25.1% margin

Net Income

$109M18.7% margin

EPS (Diluted)

$1.23

QoQ Revenue Growth

+8.0%

Cash Flow

Operating Cash Flow

$119M

Free Cash Flow

$91M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$1.5B

Total Liabilities

$1.6B

Stockholders' Equity

-$41M

Cash & Equivalents

$175M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$581M	$509M	+14.1%
Gross Profit	$332M	$293M	+13.6%
Operating Income	$146M	$123M	+18.8%
Net Income	$109M	$85M	+27.3%

Revenue Segments

Up Front Customer Loyalty Programs And Volume Commitment Programs

$975M83%

Reagent Rental Programs

$92M8%

Instrument Rebate Programs

$61M5%

Extended Warranties And Post Contract Support

$42M4%

Geographic Segments

UNITED STATES

$357M78%

Asia Pacific

$63M14%

CANADA

$26M6%

Latin America

$13M3%

IDXX Q2 2018 Earnings — IDEXX Laboratories, Inc. Revenue & Financial Results | Market Cap Arena